7 medicines held by Neuraxpharm Ireland Limited on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Dolmatil 200mg Tablets PA23229/010/001 |
Sulpiride | Neuraxpharm Ireland Limited | Marketed |
| Molipaxin 100 mg capsules PA23229/011/002 |
Trazodone hydrochloride | Neuraxpharm Ireland Limited | Marketed |
| Molipaxin 150mg Film-coated Tablets PA23229/011/003 |
Trazodone hydrochloride | Neuraxpharm Ireland Limited | Marketed |
| Molipaxin 50 mg capsules PA23229/011/001 |
Trazodone hydrochloride | Neuraxpharm Ireland Limited | Marketed |
| Nozinan 25 mg/ml solution for injection/infusion PA23229/008/001 |
LEVOMEPROMAZINE HYDROCHLORIDE | Neuraxpharm Ireland Limited | Marketed |
| Surmontil 25mg film-coated Tablets PA23229/009/002 |
Trimipramine maleate | Neuraxpharm Ireland Limited | Not marketed |
| Surmontil 50mg hard Capsules PA23229/009/001 |
Trimipramine maleate | Neuraxpharm Ireland Limited | Not marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.